ADR News Bulletin 2014 December (Volume 16 Number 3)
Healthcare professional
Industry member
Therapeutic Products
1 December 2014
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
Bulletin Highlights:
Update on trend of lymphadenitis and injection-site reactions with the BCG vaccine SSI®
Risk of thrombotic microangiopathy and nephrotic syndrome associated with the use of interferon beta products
Overseas reports of hepatic injury associated with Radix Polygoni Multiflori
Risk of cardiovascular, neurological and psychiatric adverse effects associated with bromocriptine
Launch of the new HSA website
Advisory note on use of registered thermometers
Adulteration of three health products with undeclared chemical ingredients, including sibutramine
List of Dear Healthcare Professional Letters
Risk of hypoglycaemia associated with hydroxychloroquine or chloroquine
Click on the link below to download the issue in pdf:
